Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity SONIC HEALTHCARE LIMITED
ABN | 24 004 196 909 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Colin Stephen Goldschmidt |
Date of last notice | 26 November 2019 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest | Nil |
(including registered holder) | |
Note: Provide details of the circumstances giving | |
rise to the relevant interest. | |
Date of change | 7 September 2020, 8 September 2020, 10 September 2020 |
and 11 September 2020 |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
No. of securities held prior to change | Direct |
741,230 Sonic Healthcare Limited ordinary shares | |
255,008 unlisted options over ordinary shares in Sonic | |
Healthcare Limited, issued in 2015, expiring 20 November | |
2020; exercisable at $19.41 each under the Sonic Healthcare | |
Limited Employee Option Plan having satisfied performance | |
criteria | |
164,559 unlisted options over ordinary shares in Sonic | |
Healthcare Limited, issued in 2016, expiring 17 November | |
2021; exercisable at $21.62 each under the Sonic | |
Healthcare Limited Employee Option Plan having satisfied | |
performance criteria | |
467,467 unlisted options over ordinary shares in Sonic | |
Healthcare Limited, issued in 2017 and will vest on 22 | |
November 2020, subject to performance criteria over | |
period 1 July 2017 to 30 June 2020; exercisable at $21.64 | |
each under the Sonic Healthcare Limited Employee Option | |
Plan | |
60,766 unlisted performance rights over ordinary shares in | |
Sonic Healthcare Limited, issued in 2017 and will vest on 22 | |
November 2020 subject to performance criteria over | |
period 1 July 2017 to 30 June 2020, with Nil exercise price | |
under the Sonic Healthcare Limited Performance Rights Plan | |
462,372 unlisted options over ordinary shares in Sonic | |
Healthcare Limited, issued in 2018 and will vest on 21 | |
November 2021, subject to performance criteria over | |
period 1 July 2018 to 30 June 2021; exercisable at $21.69 | |
each under the Sonic Healthcare Limited Employee Option | |
Plan | |
60,626 unlisted performance rights over ordinary shares in | |
Sonic Healthcare Limited, issued in 2018 and will vest on 21 | |
November 2021, subject to performance criteria over | |
period 1 July 2018 to 30 June 2021, with Nil exercise price | |
under the Sonic Healthcare Limited Performance Rights Plan | |
407,747 unlisted options over ordinary shares in Sonic | |
Healthcare Limited, issued in 2019 and will vest on 19 | |
November 2022, subject to performance criteria over | |
period 1 July 2019 to 30 June 2022; exercisable at $29.26 | |
each under the Sonic Healthcare Limited Employee Option | |
Plan | |
44,941 unlisted performance rights over ordinary shares in | |
Sonic Healthcare Limited, issued in 2019 and will vest on 19 | |
November 2022, subject to performance criteria over | |
period 1 July 2019 to 30 June 2022, with Nil exercise price | |
under the Sonic Healthcare Limited Performance Rights Plan | |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 | 01/01/2011 |
Appendix 3Y
Change of Director's Interest Notice
Class | Fully paid ordinary shares in Sonic Healthcare Limited |
Number acquired | |
255,008 Sonic Healthcare Limited ordinary shares acquired | |
from the exercise of options. | |
Number disposed | 250,000 ordinary shares in Sonic Healthcare Limited. |
Value/Consideration | ∙ 255,008 ordinary shares acquired on payment of |
Note: If consideration is non‐cash, provide details | $4,949,705.28 to exercise options. |
and estimated valuation | |
∙ $32.373 per share on the sale of ordinary shares. | |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3
Appendix 3Y
Change of Director's Interest Notice
No. of securities held after change | Direct | ||
746,238 Sonic Healthcare Limited ordinary shares | |||
164,559 unlisted options over ordinary shares in Sonic | |||
Healthcare Limited, issued in 2016, expiring 17 November | |||
2021; exercisable at $21.62 each under the Sonic | |||
Healthcare Limited Employee Option Plan having satisfied | |||
performance criteria | |||
467,467 unlisted options over ordinary shares in Sonic | |||
Healthcare Limited, issued in 2017 and will vest on 22 | |||
November 2020, subject to performance criteria over | |||
period 1 July 2017 to 30 June 2020; exercisable at $21.64 | |||
each under the Sonic Healthcare Limited Employee Option | |||
Plan | |||
60,766 unlisted performance rights over ordinary shares in | |||
Sonic Healthcare Limited, issued in 2017 and will vest on 22 | |||
November 2020 subject to performance criteria over | |||
period 1 July 2017 to 30 June 2020, with Nil exercise price | |||
under the Sonic Healthcare Limited Performance Rights Plan | |||
462,372 unlisted options over ordinary shares in Sonic | |||
Healthcare Limited, issued in 2018 and will vest on 21 | |||
November 2021, subject to performance criteria over | |||
period 1 July 2018 to 30 June 2021; exercisable at $21.69 | |||
each under the Sonic Healthcare Limited Employee Option | |||
Plan | |||
60,626 unlisted performance rights over ordinary shares in | |||
Sonic Healthcare Limited, issued in 2018 and will vest on 21 | |||
November 2021, subject to performance criteria over | |||
period 1 July 2018 to 30 June 2021, with Nil exercise price | |||
under the Sonic Healthcare Limited Performance Rights Plan | |||
407,747 unlisted options over ordinary shares in Sonic | |||
Healthcare Limited, issued in 2019 and will vest on 19 | |||
November 2022, subject to performance criteria over | |||
period 1 July 2019 to 30 June 2022; exercisable at $29.26 | |||
each under the Sonic Healthcare Limited Employee Option | |||
Plan | |||
44,941 unlisted performance rights over ordinary shares in | |||
Sonic Healthcare Limited, issued in 2019 and will vest on 19 | |||
November 2022, subject to performance criteria over | |||
period 1 July 2019 to 30 June 2022, with Nil exercise price | |||
under the Sonic Healthcare Limited Performance Rights Plan | |||
+ See chapter 19 for defined terms.
Appendix 3Y Page 4 | 01/01/2011 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Sonic Healthcare Limited published this content on 14 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 September 2020 07:34:05 UTC